Resistance Exercise Training at Different Intensities

March 24, 2020 updated by: Stuart Gray, University of Glasgow

Resistance Exercise Training at Different Intensities in Healthy and Frail Older People: A Feasibility Study

The aim of the current study, therefore, is to determine the feasibility of recruitment and adherence to resistance exercise training interventions performed at low and high loads, to volitional muscular failure, in a trial population that includes both healthy and frail older people.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Glasgow, United Kingdom, G12 8TA
        • GRI Clinical Research Facility

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Over age of 65 years

Exclusion Criteria:

  • Current participation in an exercise programme
  • Exercise deemed unsafe by clinical team

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low load
Training at 30-40% one-repetition maximum (1RM)
leg extension, leg press, leg curl and calf press
Experimental: High load
Training at 65-75% one-repetition maximum (1RM)
leg extension, leg press, leg curl and calf press

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle strength
Time Frame: Change from baseline to 8 weeks
Knee extensor maximal torque during an isometric MVC
Change from baseline to 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vastus lateralis muscle thickness
Time Frame: Change from baseline to 8 weeks
Measured via ultrasound
Change from baseline to 8 weeks
Muscle strength
Time Frame: Change from baseline to 8 weeks
Knee flexor maximal torque during an isometric MVC
Change from baseline to 8 weeks
One-repetition maximum
Time Frame: Change from baseline to 8 weeks
leg extension, leg curl, leg press and calf press
Change from baseline to 8 weeks
Biomechanics during walking and stair climbing
Time Frame: Change from baseline to 8 weeks
Motion analysis
Change from baseline to 8 weeks
Short performance physical battery test
Time Frame: Change from baseline to 8 weeks
SPPB - balance, walking pace and chair rise
Change from baseline to 8 weeks
Quality of life measure
Time Frame: Change from baseline to 8 weeks
EQ-5D-5L questionnaire
Change from baseline to 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stuart Gray, University of Glasgow

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Actual)

December 18, 2019

Study Completion (Actual)

December 18, 2019

Study Registration Dates

First Submitted

August 9, 2019

First Submitted That Met QC Criteria

August 9, 2019

First Posted (Actual)

August 13, 2019

Study Record Updates

Last Update Posted (Actual)

March 25, 2020

Last Update Submitted That Met QC Criteria

March 24, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on Low Load Resistance exercise

3
Subscribe